The company has partnered with Nvidia to develop “cognitive AI,” which it says will allow people with severe physical disabilities to have more natural interactions with the world around them.
The mRNA technology behind coronavirus vaccines is now being used to create bespoke vaccines for cancer patients.
The de-extinction company Colossal Biosciences wants to bring back the woolly mammoth—starting with a very furry mouse.
Biohacker Josie Zyner’s new company, Los Angeles Project, is creating a new generation of gene-edited pets.
Startup Canaery is partnering with a US Department of Energy lab to develop neural implants for rats and dogs that are capable of decoding what they smell.
The FDA recently approved a bioengineered blood vessel, which becomes part of a patient’s body over time. It’s designed to help treat victims of traumatic injuries.
When a US research lab accidentally created a sticky web-like substance, it turned to Peter Parker and comic-book lore for inspiration on what to do next.
When a US research lab accidentally created a sticky web-like substance, it turned to Peter Parker and comic-book lore for inspiration on what to do next.
What may be the first commercially available book saved in DNA is the latest example of how consumers might use molecular data storage.
The first medical treatment to use Crispr gene editing has been on the market for a year. Its complexity means few patients in the US have received it yet.
